Quarterly report · Q3
6942.TEDINET S100SW6D
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.8bn | 2023-04-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥9.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.2bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥237m | 2023-04-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥283m | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥218m | 2023-04-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥399m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥307m | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥219m | 2023-04-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥184m | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥55m | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥21m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥47m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥55m | 2023-04-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥47m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥7.1bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥7.4bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥7.5bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.7bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥5.4bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.4bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥2.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.1bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.0bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥19.78 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.9 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.85 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.38 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.24 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥19.6 | 2023-04-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 33.2% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.4% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.2% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 41
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-12-31 | −¥14m |
| jpcrp040300-q3r_E01978-000Dispensing Pharmacy And Related Businessreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥5.4bn |
| jpcrp040300-q3r_E01978-000Dispensing Pharmacy And Related Businessreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥5.4bn |
| jpcrp040300-q3r_E01978-000Dispensing Pharmacy And Related Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥7m |
| jpcrp040300-q3r_E01978-000Dispensing Pharmacy And Related Businessreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥278m |
| jpcrp040300-q3r_E01978-000Internet Related Businessreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥1.3bn |
| jpcrp040300-q3r_E01978-000Internet Related Businessreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥1.3bn |
| jpcrp040300-q3r_E01978-000Internet Related Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥3m |
| jpcrp040300-q3r_E01978-000Internet Related Businessreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥105m |
| jpcrp040300-q3r_E01978-000Telecommunications Businessreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥128m |
| jpcrp040300-q3r_E01978-000Telecommunications Businessreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥124m |
| jpcrp040300-q3r_E01978-000Telecommunications Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥4m |
| jpcrp040300-q3r_E01978-000Telecommunications Businessreportable segment | segment profit | 2023-04-01 → 2023-12-31 | −¥31m |
| —segment total | revenue | 2023-04-01 → 2023-12-31 | ¥6.8bn |
| —segment total | revenue external | 2023-04-01 → 2023-12-31 | ¥6.8bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥15m |
| —segment total | segment profit | 2023-04-01 → 2023-12-31 | ¥353m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-12-31 | ¥6.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-12-31 | ¥6.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥15m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-12-31 | ¥339m |
| jpcrp040300-q3r_E01978-000Dispensing Pharmacy And Related Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥5.1bn |
| jpcrp040300-q3r_E01978-000Dispensing Pharmacy And Related Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥5.1bn |
| jpcrp040300-q3r_E01978-000Dispensing Pharmacy And Related Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥7m |
| jpcrp040300-q3r_E01978-000Dispensing Pharmacy And Related Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥197m |
| jpcrp040300-q3r_E01978-000Internet Related Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.1bn |
| jpcrp040300-q3r_E01978-000Internet Related Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥1.1bn |
| jpcrp040300-q3r_E01978-000Internet Related Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥8m |
| jpcrp040300-q3r_E01978-000Internet Related Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥102m |
| jpcrp040300-q3r_E01978-000Telecommunications Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥926m |
| jpcrp040300-q3r_E01978-000Telecommunications Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥923m |
| jpcrp040300-q3r_E01978-000Telecommunications Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥3m |
| jpcrp040300-q3r_E01978-000Telecommunications Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥8m |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥7.2bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥7.2bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥18m |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥307m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥7.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥7.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥18m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥307m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 374
| Item | Context | Value | Unit |
|---|---|---|---|
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in scope of consolidation or equity method (text) | CurrentYTDDuration | Text · Plus | |
| Notes additional information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding presentation of accumulated impairment loss (text) | CurrentQuarterInstant | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | CurrentQuarterInstant | Text · Plus | |
| Notes regarding financial covenant (text) | CurrentQuarterInstant | Text · Plus | |
| Special survey costs etc (text) | CurrentYTDDuration | Text · Plus | |
| Description of fact that quarterly statement of cash flows has not been prepared (text) | CurrentYTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1YTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Description of nature of differences between profit loss of reportable segments total and quarterly financial statements (text) | Prior1YTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Description of nature of differences between profit loss of reportable segments total and quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Disclosure of changes etc in reportable segments (text) | CurrentYTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |